Baseline neutrophil-to-lymphocyte ratio and c-reactive protein predict efficacy of treatment with bevacizumab plus paclitaxel for locally advanced or metastatic breast cancer

JOURNAL ARTICLE published 7 January 2020 in Oncotarget

Authors: Yoshimasa Miyagawa | Ayako Yanai | Takehiro Yanagawa | Junichi Inatome | Chiyomi Egawa | Arisa Nishimukai | Kaori Takamoto | Takashi Morimoto | Yuichiro Kikawa | Hirofumi Suwa | Tomoe Taji | Ai Yamaguchi | Yuki Okada | Atsushi Sata | Reiko Fukui | Ayako Bun | Hiromi Ozawa | Tomoko Higuchi | Yukie Fujimoto | Michiko Imamura | Yasuo Miyoshi